DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,864 | +10.6% | 18,700 | +22.5% | 0.00% | – |
| Q2 2023 | $215,016 | -5.9% | 15,271 | +0.4% | 0.00% | – |
| Q1 2023 | $228,529 | +16.8% | 15,215 | +27.5% | 0.00% | – |
| Q4 2022 | $195,664 | -93.4% | 11,938 | -96.1% | 0.00% | -100.0% |
| Q4 2021 | $2,974,000 | -70.3% | 304,451 | +3.3% | 0.00% | -71.4% |
| Q3 2021 | $10,017,000 | -7.3% | 294,803 | -0.1% | 0.01% | 0.0% |
| Q2 2021 | $10,807,000 | -8.5% | 295,201 | +12.1% | 0.01% | -22.2% |
| Q1 2021 | $11,809,000 | -3.7% | 263,359 | +22.6% | 0.01% | -10.0% |
| Q4 2020 | $12,259,000 | +18.4% | 214,802 | +6.4% | 0.01% | +11.1% |
| Q3 2020 | $10,357,000 | +10.4% | 201,896 | +28.5% | 0.01% | 0.0% |
| Q2 2020 | $9,383,000 | +222.1% | 157,114 | +122.1% | 0.01% | +200.0% |
| Q1 2020 | $2,913,000 | – | 70,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |